LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 78 filers reported holding LEGEND BIOTECH CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $432,341,922 | -2.7% | 6,436,533 | 0.0% | 9.65% | +2.0% |
| Q2 2023 | $444,313,873 | +79.6% | 6,436,533 | +25.5% | 9.46% | +115.7% |
| Q1 2023 | $247,386,297 | -3.5% | 5,130,367 | -0.1% | 4.39% | -19.0% |
| Q4 2022 | $256,419,921 | +22.4% | 5,136,617 | 0.0% | 5.41% | -1.8% |
| Q3 2022 | $209,574,000 | -14.1% | 5,136,617 | +15.8% | 5.51% | +5.4% |
| Q2 2022 | $244,014,000 | -3.2% | 4,436,617 | -36.0% | 5.23% | -0.6% |
| Q1 2022 | $252,077,000 | -54.2% | 6,936,617 | -41.2% | 5.26% | -38.1% |
| Q4 2021 | $550,228,000 | -1.6% | 11,804,925 | +6.8% | 8.50% | +16.3% |
| Q3 2021 | $558,937,000 | +1994.7% | 11,054,925 | +1600.8% | 7.31% | +2558.2% |
| Q2 2021 | $26,683,000 | +41.5% | 650,000 | 0.0% | 0.28% | +47.8% |
| Q1 2021 | $18,863,000 | +3.1% | 650,000 | 0.0% | 0.19% | +27.4% |
| Q4 2020 | $18,304,000 | -8.8% | 650,000 | 0.0% | 0.15% | -3.9% |
| Q3 2020 | $20,066,000 | -27.5% | 650,000 | 0.0% | 0.15% | -39.9% |
| Q2 2020 | $27,664,000 | – | 650,000 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 1,629,173 | $66,470,000 | 19.56% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,466,453 | $59,831,000 | 8.69% |
| Paradigm Biocapital Advisors LP | 1,076,591 | $43,925,000 | 5.86% |
| HHLR ADVISORS, LTD. | 5,136,617 | $209,574,000 | 5.51% |
| RA Capital Management | 2,338,610 | $95,415,000 | 2.04% |
| Nicholas Investment Partners, LP | 399,486 | $16,299,000 | 1.51% |
| Parkman Healthcare Partners LLC | 121,227 | $4,946,000 | 1.41% |
| Capital International, Inc./CA/ | 1,244,362 | $50,770,000 | 1.13% |
| AtonRa Partners | 28,150 | $1,149,000 | 1.13% |
| Vivo Capital, LLC | 244,375 | $9,971,000 | 1.10% |